Option chain shows key data for Terra Property Trust, Inc. 6.00% Notes due 2026's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Terra Property Trust, Inc. 6.00% Notes due 2026.

Terra Property Trust, Inc. 6.00% Notes due 2026 (NYSE:TPTA) Stock, Option Chain

Terra Property Trust, Inc. 6.00% Notes due 2026

Bill Gates isn't just a tech billionaire or a global philanthropist – he's also one of the biggest farmland owners in the United States. With <a href="https://www.benzinga.com/real-estate/24/07/39797332/bill-gates-owns-275-000-acres-of-u-s-farmland-his-answer-to-why-hes-buying-so-much-of-it-might-surpr">275,000 acres spread across 18 states</a>, Gates has quietly built an agricultural empire that includes everything from soybeans in Nebraska to carrots in Florida. However, perhaps the most interesting connection from his massive landholdings is this: some of the potatoes grown on his farms end up as McDonald's french fries. And, as if that weren't ironic enough, Gates also owns a McDonald's Gold Card, which means he can eat those fries for free.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/advisor-adv-warren-buffett">Warren Buffett Flipped His Neighbor's $67,000 Life Savings Into A $50 Million Fortune — This Would Be Worth Over $500 Million Today</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li><a href="https://www.benzinga.com/money/cd-valet-growth">CD Popularity Soars: Over 50 Million Americans Embrace Safe Savings with 5–10% Annual Growth</a></li>
</ul>
Yes, the man who revolutionized personal computing has a hand in the french fries you're dunking in ketchup. One of his most prominent properties, 100 Circle Farms in Washington State,<a href="https://www.benzinga.com/real-estate/24/07/39959226/yes-its-true-bill-gates-275-000-acres-of-farmland-grows-the-potatoes-for-mcdonalds-french-fries"> grows the spuds that supply McDonald's</a>. While not every fry at the Golden Arches comes from Gates-owned land, his connection to the fast-food giant is undeniable. It's a full-circle story: Gates invests in farmland, some of that farmland grows potatoes and those potatoes may end up on McDonald's trays – where Gates can walk in, Gold Card in hand and order a free meal.&nbsp;
The McGold Card is a rarity, given only to a select few. Gates joins a small club of recipients that includes Warren Buffett and actor Rob Lowe. It's essentially a lifetime pass for free McDonald's food, a perk that's more amusing than practical for someone whose net worth sits comfortably north of $100 billion. Unlike <a href="https://www.benzinga.com/personal-finance/24/08/40257868/bill-gates-says-warren-buffett-treated-him-to-lunch-at-mcdonalds-you-offered-to-pay-dug-into-you">Buffett's, which is limited just to his hometown of Omaha</a>, Gates' is good worldwide.&nbsp;
Gates insists his farmland investments are purely financial, explaining in a Reddit AMA that they're not connected to climate initiatives or grand strategy. Farmland is a stable and appreciating asset, especially in a world where feeding a growing population is becoming more critical by the year. Yet, the sheer scale of his holdings has raised eyebrows. Critics worry about billionaires driving up land prices and edging out smaller, younger farmers. Nearly 40% of U.S. farmland is owned by people over 65, making the sector ripe for generational turnover, but that transition isn't so straightforward when billionaires are in the mix.
Trending: Invest in $20+ trillion home equity market today across cities like Austin, Miami, and Los Angeles through a <a href="https://www.benzinga.com/money/nada-cityfunds">unique 5-year term fund targeting a 14-20% IRR with minimums as low as $2,500</a>
For Gates, though, it's business as usual. His land holdings are managed by professional investment firms overseeing many crops beyond potatoes, including soybeans, corn, cotton and onions. His 14,500-acre potato farm in Washington, big enough to be seen from space, is just one piece of a much larger puzzle. And while his farms might be producing some of the nation's food staples, they also tie into his broader philanthropic goals. Revenue from his farmland portfolio helps fund initiatives through the Bill &amp; Melinda Gates Foundation, including global health programs.
The intersection of Gates' wealth, farmland ownership and fast food is unexpected and strangely fitting. It's not every day that a billionaire with a McDonald's Gold Card also happens to own the land where some of the fries are grown. Whether you see it as a <a href="https://www.benzinga.com/personal-finance/24/11/41949050/bill-gates-warned-the-u-s-will-experience-another-2008-style-financial-crisis-he-cant-predict-when-but-says-this-is-a-certainty">clever investment strategy or just a coincidence,</a> it reminds you of how deeply interconnected the modern world is – even down to the fries on your tray.
Read Next:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">You can still get 4,000 of its pre-IPO shares for with $1,000 for just $0.25/share</a></li>
</ul>

Personal Finance

Bill Gates Owns 275,000 Acres Of Farmland Which Grows Potatoes For McDonald's Fries – And He Eats Them Free Thanks To His Rare McGold Card

B of A Securities analyst Steve Byrne maintains Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) with a Buy and raises the price target from $67 to $69.

News

Price Target

Analyst Ratings

CTVA

B of A Securities Maintains Buy on Corteva, Raises Price Target to $69

ZIM Integrated Shipping Services Ltd&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) shares are trading higher after it reported a&nbsp;third-quarter sales increase of&nbsp;117% year over year to&nbsp;$2.77&nbsp;billion,&nbsp;beating&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42084671/zim-reports-financial-results-for-the-third-quarter-of-2024-raises-full-year-2024-guidance" rel="noreferrer noopener">the consensus of&nbsp;$2.43 billion</a>.
Revenue was driven by the increase in freight rates as well as carried volume. The cargo shipping company&#8217;s carried volume in the quarter was 970 thousand TEUs, up 12% Y/Y. The average freight rate per TEU was $2,480 (+118% Y/Y).
Adjusted EBITDA escalated&nbsp;626%&nbsp;Y/Y&nbsp;to&nbsp;$1.53&nbsp;billion, with margins of&nbsp;55% vs.&nbsp;17%&nbsp;in the prior year quarter.&nbsp;&nbsp;
The Haifa, Israel-based company generated an EPS of&nbsp;$9.34, vs a loss of&nbsp;$18.90 last year,&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beating the consensus of&nbsp;$7.20</a>.
Operating cash flow for the nine months was&nbsp;$2.60&nbsp;billion, compared to&nbsp;$858&nbsp;million a year ago.&nbsp;Capital expenditures were&nbsp;$50&nbsp;million during the quarter versus&nbsp;$14&nbsp;million a year ago.
ZIM&#8217;s&nbsp;total cash position increased&nbsp;by&nbsp;$441&nbsp;million from&nbsp;$2.69&nbsp;billion as of&nbsp;December 31, 2023,&nbsp;to&nbsp;$3.13&nbsp;billion as of&nbsp;September 30, 2024.
ZIM&#8217;s&nbsp;net leverage ratio was 0.9x&nbsp;as of September-end, compared to 2.2x as of&nbsp;December 31, 2023.
Dividend: The Board of Directors declared a regular cash dividend of $340 million ($2.81 per share), representing 30% of third-quarter 2024 net income, and a special dividend of $100 million ($0.84 per share).
The total dividend of $440 million ($3.65 per share) will be payable on December 9, 2024, to shareholders of record as of December 2, 2024.
2024&nbsp;Outlook: ZIM raised the adjusted EBITDA&nbsp;outlook to $3.3 billion &#8211; $3.6 billion (from&nbsp;$2.6 billion &#8211; $3 billion) and adjusted EBIT to&nbsp;$2.15 billion &#8211; $2.45 billion <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">(from $1.45 billion &#8211; $1.85 billion&nbsp;prior)</a>.
Eli Glickman, ZIM President &amp;&nbsp;CEO,&nbsp;said, &#8220;We will close out the year with the final delivery of the remaining four out of 46 newbuild containerships that we secured, which include 28 LNG-powered vessels. Entering 2025, we will be operating a fleet that is both well-equipped to meet emissions reduction targets and well suited to the trades in which we operate.&#8221;
Investors can gain exposure to the stock via&nbsp;Tidal Trust II YieldMax Ultra Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULTY#NYSE">ULTY</a>) and SonicShares Global Shipping ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOAT#NYSE">BOAT</a>).
Price Action: ZIM shares are up 8.10% at $28.95 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41818419/jpmorgan-flags-imax-h-b-fuller-zim-as-top-short-picks-with-challenges" target="_blank" rel="noreferrer noopener">JPMorgan Flags IMAX, H.B. Fuller, ZIM As Top Short Picks With Challenges</a></li>
</ul>

Earnings

Equities

Mid Cap

Guidance

Dividends

Movers

BOAT

ULTY

Israel-Based Cargo Shipping Company ZIM Integrated Smashes Estimates With 626% EBITDA Growth, Upgrades 2024 Outlook

On Monday, Chinese semiconductor leaders and investors convened in Beijing for the 21st China International Semiconductor Expo, focusing on strategies to navigate U.S. restrictions and bolster local chip production capabilities.
The event, which gathered over 500 companies across design, foundry, and packaging sectors, highlighted the impact of Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) scaling back advanced foundry services for Chinese firms, alongside the geopolitical challenges posed by a second Donald Trump administration.
Despite these hurdles, experts at the expo emphasized China&#8217;s growth potential in advanced semiconductors and generative AI, citing its expansive market as a significant driver, SCMP <a target="_blank" href="https://www.scmp.com/tech/tech-war/article/3287277/tsmcs-move-cut-chinese-chip-firms-weighs-annual-beijing-semiconductor-forum?module=perpetual_scroll_0&amp;pgtype=article" rel="noreferrer noopener">reports</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/24/11/41984426/nvidia-powers-teslas-humanoid-robots-with-new-ai-tech-heres-what-to-expect-in-2025" rel="noreferrer noopener">Nvidia Powers Tesla&#8217;s Humanoid Robots With New AI Tech: Here&#8217;s What To Expect In 2025</a>
BASiC Semiconductor co-founder He Weiwei discussed the company&#8217;s increased investment of up to $4.1 million to mitigate supply chain risks. He highlighted how U.S. sanctions and technological decoupling have strained the industry, forcing startups like BASiC to localize manufacturing processes.
Similarly, Moore Threads Technology co-founder Dong Longfei stressed the collaborative efforts needed between government, industry, and academia to advance domestic GPU production through alternative methods like chiplets.
The expo also addressed China&#8217;s challenges in developing cutting-edge semiconductor technology. Experts noted that Chinese fabs must catch up to Taiwan Semiconductor in advanced nodes, a gap exacerbated by export restrictions.
However, domestic companies are exploring innovative solutions to overcome these barriers and sustain competitiveness.
During the event, executives also discussed international partnerships, with Liu Yuanchao of the China Semiconductor Industry Association emphasizing the potential for collaboration between China and South Korea.
He pointed out the complementary nature of the two countries&#8217; semiconductor industries, which could drive mutual growth in the sector.
Amid growing semiconductor demand, Taiwan Semiconductor has seen rising sales from Shenzhen manufacturers producing smart hardware. However, the company&#8217;s recent move to limit services for Chinese clients using advanced nodes has amplified local firms&#8217; challenges as they strive to innovate while adapting to geopolitical pressures.
In November, the Biden government imposed sanctions on Taiwan Semiconductor, prohibiting advanced <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/24/11/41883357/taiwan-semiconductor-stock-drops-as-us-orders-halt-on-ai-chip-sales-to-china" rel="noreferrer noopener">AI chip sales to China</a>. During his presidential campaign, Trump had attacked China, sharing his plans to slap <a target="_blank" href="https://www.benzinga.com/government/24/11/41773691/us-listed-chinese-stocks-like-alibaba-jd-nio-fall-after-trumps-win-whats-going-on" rel="noreferrer noopener">tariffs on exports</a> to the country.
Taiwan Semiconductor stock gained 87% year-to-date thanks to the artificial intelligence frenzy.
The contract chipmaker plans to build over ten new semiconductor facilities globally by 2025, ramping up <a target="_blank" href="https://www.benzinga.com/government/regulations/24/11/42032114/taiwan-semiconductor-plans-major-global-expansion-sets-record-38-billion-investment-target" rel="noreferrer noopener">advanced production capacity</a>.
Projects include cutting-edge 2nm fabs in Taiwan and a second plant in Japan&#8217;s Kumamoto region, which is set for construction in 2025.
Taiwan Semiconductor is advancing facilities in Arizona and Dresden while developing advanced packaging technologies like CoWoS and SoIC.
Capital expenditures could hit a record $34-$38 billion in 2025, driven by surging demand for high-tech semiconductor manufacturing.
Taiwan Semiconductor bagged <a target="_blank" href="https://www.benzinga.com/24/11/42060003/taiwan-semiconductors-us-subsidy-boosts-a16-tech-production-in-arizona" rel="noreferrer noopener">$6.6 billion in</a> U.S. subsidies and proposed up to $5 billion in loans&nbsp;for A16 chip production in Arizona under the CHIPS&nbsp;Act.
Price Action: At the last check on Wednesday, TSM stock was lower by 0.05% at $189.57 premarket.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41985546/rivian-volkswagen-deal-strengthens-finances-yet-ev-market-risks-remain-goldman-sachs" target="_blank" rel="noreferrer noopener">Rivian-Volkswagen Deal Strengthens Finances, Yet EV Market Risks Remain: Goldman Sachs</a></li>
</ul>
Photo by Ivan Marc via Shutterstock

Government

Regulations

Emerging Markets

Tech

Media

Taiwan Semiconductor Faces China Challenges Amid Potential Geopolitical Tensions From Trump Return

During China's Double 11 shopping holiday, smartphone brands had strong sales, with Apple, Xiaomi, and Honor performing particularly well.

AAPL

"Apple, Xiaomi and Honor Sell Well During China Double 11" - DigiTimes

WIIM

OKLO

Oklo shares are trading lower after Kerrisdale issued a short report on the stock.

<a href="https://x.com/KerrisdaleCap/status/1859237692191469941" title="https://x.com/KerrisdaleCap/status/1859237692191469941">https://x.com/KerrisdaleCap/status/1859237692191469941</a>

Short Sellers

Watching Oklo Shares After Kerrisdale Issues Short Report

Global

"According To Industry Sources, TSMC Is Discreetly Establishing An Industry Cluster For Advanced Packaging On 30 Hectares Of Land In The Southern Taiwan Science Park" - DigiTimes Alert

<a href="https://ir.delta.com/events-and-presentations/events-calendar/event-details/2024/2024-Investor-Day/default.aspx" title="https://ir.delta.com/events-and-presentations/events-calendar/event-details/2024/2024-Investor-Day/default.aspx">https://ir.delta.com/events-and-presentations/events-calendar/event-details/2024/2024-Investor-Day/default.aspx</a>

Events

Delta Air Lines CEO At Investor Day, Says The Airline's Consumer Is Healthy; Demand For International Travel Continues To Grow

Collaboration will combine Vyriad's lentiviral vector platform and Novartis expertise and leadership in cell therapy innovation
ROCHESTER, Minn., Nov. 20, 2024 /PRNewswire/ -- Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced a strategic collaboration with Novartis to discover and develop in vivo chimeric antigen receptor (CAR) T-cell therapies.
The collaboration will leverage Vyriad's active targeting lentiviral vector platform and Novartis expertise and leadership in cell therapy innovation. Novartis and Vyriad will focus on the identification and development of in vivo CAR-T cell therapy candidates to be clinically advanced by Novartis. Vyriad will receive an upfront payment, milestone payments, and tiered royalties on each program.

Biotech

General

Vyriad Announces Strategic Collaboration With Novartis To Develop In Vivo CAR-T Cell Therapies, Will Combine Vyriad's Lentiviral Vector Platform And Novartis Expertise And Leadership In Cell Therapy Innovation

PRTS

CarParts.com Partners With SimpleTire To Add Over 300 Tire Brands, Expanding Customer Options With 55M Tires And 10,000 Installers Nationwide

Medical marijuana telehealth company Leafwell is partnering with the Oklahoma-based cannabis retailer, Mango Cannabis.
Under this collaboration, Mango Cannabis will expand its offerings to include virtual clinical care for its patients. This will increase patient access and education, enabling patients to receive their medical marijuana cards through an expedited and streamlined process.
"Mango Cannabis has always put the patients first," stated Jon Pattah, chief marketing officer of Mango Cannabis. "Virtual clinics allow more people access to informed cannabis care or a medical marijuana card. Through this partnership, we can offer patients across different states a safe and specialized healthcare experience."
Mango employees will direct qualified patients to Leafwell's platform to connect with state-licensed physicians through a virtual clinic, providing access to hundreds of healthcare providers in more than 30 specialties. This will allow patients to receive customized care, rather than a one-size-fits-all approach to their individual health needs.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h2 class="wp-block-heading">Cannabis Equals Versatility </h2>
"Cannabis has the versatility to help with a myriad of conditions. At Leafwell, we connect you to cannabis-knowledgeable healthcare providers online in minutes so that you can incorporate cannabis into your treatment plan with confidence. Leafwell ensures you have access to convenient quality care when you need it," stated Leafwell CEO and founder Emily Fisher. "Our partnership with Mango Cannabis will allow our current and future patients to receive personalized care plans for someone based on their illness or diagnosis. We look forward to working with Mango Cannabis with the overall goal of enhancing the lives of our customers."
An abundance of mainstream medical research shows cannabis can relieve a variety of physical and mental ailments, including anxiety, <a href="https://www.benzinga.com/markets/cannabis/24/01/36578723/huge-study-reveals-cannabis-provides-similar-pain-relief-benefits-as-opioids-without-negative-co">chronic pain</a>, <a href="https://www.benzinga.com/markets/cannabis/22/08/28637449/thc-is-beneficial-for-ptsd-treatment-new-study-reveals">PTSD</a>, and side effects from chemotherapy, to name a few. With Mango Cannabis's recent expansion into new regulated markets across the country, this partnership enables the MSO to access medical care it might not otherwise provide. In addition to specialized medical care, patients will also benefit from seven-day-a-week care support and access to a library of patient education resources.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41809974/cannabis-extract-significantly-reduces-chemotherapy-induced-vomiting-tilray-backed-study-reveals">Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals</a>
In addition to the partnership, Mango Cannabis recently entered the Michigan market and is set to open locations in New York and New Mexico in the near future.
Meanwhile, Leafewell recently published the results of its <a href="https://www.benzinga.com/general/health-care/24/11/41972708/exclusive-study-of-81000-patients-uncovers-who-uses-medical-marijuana-their-top-health-concerns">study of 81,000 patients</a>, uncovering who uses medical marijuana and for which conditions. The research, &#8220;The Real Faces Of Medical Cannabis: Surprising Insights From 81,000 Patients,&#8221; reveals that the majority (58%) of patients report multiple conditions, with the average person managing two or more. The three most common conditions are chronic pain (32%), anxiety (26.8%) and PTSD (11.2%).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42024344/cannabis-could-save-29-billion-per-year-in-u-s-healthcare-costs-says-ceo">Cannabis Could Save $29 Billion Per Year In U.S. Healthcare Costs, Says CEO</a></li>
</ul>
Photo: Courtesy of Roxana Gonzalez on Shutterstock

Cannabis

Virtual Marijuana Clinic Leafwell Partners With Mango Cannabis To Improve Patient Access

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.planet.com%2F%3Futm_medium%3Demail%26utm_source%3Dgovdelivery%26restored%3D1726179596175%26restored%3D1726501133544%26restored%3D1727239916502&amp;esheet=54155504&amp;newsitemid=20241120268553&amp;lan=en-US&amp;anchor=Planet+Labs+PBC&amp;index=1&amp;md5=38916a6bee276b27b93f50c123317d25">Planet Labs PBC</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>), a leading provider of daily data and insights about Earth, today announced a new contract with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fglobalfishingwatch.org%2F&amp;esheet=54155504&amp;newsitemid=20241120268553&amp;lan=en-US&amp;anchor=Global+Fishing+Watch&amp;index=2&amp;md5=a4d8b6839bb716d43b5cdaf5ad97e522">Global Fishing Watch</a>, an international nonprofit dedicated to advancing ocean governance through increased transparency of human activity at sea. The 6-figure deal is an expansion of the organization's ongoing agreement with Planet, and will allow Global Fishing Watch to fully leverage PlanetScope data and Machine Learning (ML) to improve ocean stewardship and foster greater compliance and accountability across all maritime sectors.
The new contract represents a significant expansion of Global Fishing Watch's PlanetScope monitoring coverage, providing 3-meter optical imagery spanning most of the world's coastlines. With this heightened capability, Global Fishing Watch aims to map small vessel activity across millions of square kilometers of the ocean as far from the shoreline as possible. This will allow the organization to greatly augment its ability to detect small vessels that are not using Automatic Identification Systems (AIS) or Vessel Monitoring Systems (VMS), enabling more accurate determination of fishing activities and better support for ocean governance efforts around the world.

Contracts

Planet Labs Announced 6-Figure Contract Expansion With Global Fishing Watch To Enhance Ocean Governance Using PlanetScope Data And Machine Learning

DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus&#xAE; control group in both body weight-loss, by 11.53% and 10.65% respectively, and in blood sugar, by 11.13% and 3.35% respectively.
DehydraTECH-semaglutide compositions with and without SNAC technology outperformed Rybelsus&#xAE; control in body weight
Weight-control improvement demonstrated in ALL study groups during the final 4-weeks
Outcomes are strongly supportive of pending <a href="https://lexariabioscience.com/2024/11/13/ethics-board-approval-granted-for-lexarias-12-week-phase-1b-dehydratech-glp-1-study-in-diabetes-and-weight-loss/">Phase 1b Australian human study</a>

LEXX

Lexaria Bioscience Received Final 12-week Body Weight And Blood Sugar Results From All 12 Study Groups Of The Recently Completed Diabetes Animal Study Weight-A24-1

SYLA Technologies Updates 2024 Revenue Guidance From ¥27.5M-¥30M To ¥29M

<a href="https://www.globenewswire.com/Tracker?data=4GZpIEu2d16il0Tl-LJm2DBJxFpUrIRI0js8J9yj79bqizAIRkseFmTBOSJ9zRRIW7synvg447XVcj9Oi3OOOl3Mfh8C3Zhq2gVvWePCrN8=">Varonis Systems, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>), today announced the expansion of its IaaS security coverage to Google Cloud. The latest integration broadens Varonis' extensive coverage portfolio, bringing the company's proven data-centric approach to Google Cloud storage and data warehouses.
Data is a prime target for attackers, but discovering where sensitive data lives and remediating risk across sprawling cloud environments is virtually impossible without automation. Other tools simply monitor configurations. Varonis focuses on data, providing comprehensive visibility while automatically identifying and resolving data risk issues.
With Varonis, customers can continuously strengthen their data security posture, help prevent data breaches, and maintain a state of least privilege across cloud environments.

VRNS

Varonis Extends Cloud Data Security Coverage To Google Cloud

BMO Capital analyst Keith Tapper maintains Neurogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) with a Outperform and lowers the price target from $60 to $45.

NGNE

BMO Capital Maintains Outperform on Neurogene, Lowers Price Target to $45

FBRX

Forte Biosciences Secures $53M In Oversubscribed Private Placement To Advance FB102 Clinical Programs Across Autoimmune Indications, With Key Data Readouts Expected In 2025

BMO Capital analyst Ketan Mamtora maintains AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) with a Market Perform and raises the price target from $49 to $51.

AZEK

BMO Capital Maintains Market Perform on AZEK Co, Raises Price Target to $51

Palladyne AI Congratulates Red Cat on U.S. Army's Short Range Reconnaissance Program of Record Award

Comments

Terra Property Trust, Inc. 6.00% Notes due 2026

Terra Property Trust, Inc. 6.00% Notes due 2026 (TPTA) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga